Holmes Scott A 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Oct 30, 2018
Insider Transaction Report
Form 4
Holmes Scott A
Chief Financial Officer
Transactions
- Sale
Common Stock
2018-10-29$3.07/sh−1,254$3,850→ 164,111 total
Footnotes (2)
- [F1]Sale of a total of 1,254 shares of common stock was made in order to satisfy Mr. Holmes' income tax withholding obligation upon the vesting of 4,479 shares of restricted stock on October 28, 2018. Mr. Holmes had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 70,102 shares of restricted stock.